Raymond James & Associates’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $1.76M | Sell |
49,027
-51,723
| -51% | -$1.86M | ﹤0.01% | 2293 |
|
|
2024
Q2 | $3.56M | Sell |
100,750
-68,213
| -40% | -$2.41M | ﹤0.01% | 1811 |
|
|
2024
Q1 | $4.8M | Buy |
168,963
+82,466
| +95% | +$2.34M | ﹤0.01% | 1607 |
|
|
2023
Q4 | $1.15M | Sell |
86,497
-1,741
| -2% | -$23.2K | ﹤0.01% | 2425 |
|
|
2023
Q3 | $791K | Buy |
88,238
+16,240
| +23% | +$146K | ﹤0.01% | 2596 |
|
|
2023
Q2 | $810K | Sell |
71,998
-5,205
| -7% | -$58.6K | ﹤0.01% | 2592 |
|
|
2023
Q1 | $889K | Buy |
77,203
+21,836
| +39% | +$252K | ﹤0.01% | 2504 |
|
|
2022
Q4 | $642K | Sell |
55,367
-2,840
| -5% | -$32.9K | ﹤0.01% | 2708 |
|
|
2022
Q3 | $739K | Buy |
+58,207
| New | +$739K | ﹤0.01% | 2577 |
|